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Abstract
A novel class of 6-indolypyridine-3-carbonitrilile derivatives were synthesized and evaluated for
antiproliferative activities to establish structure-activity relationship. The synthesis was carried out
through one-pot multicomponent reaction of 3-acetylindole, aromatic aldehydes, ethyl
cyanoacetate, and ammonium acetate in the presence of piperidine as a catalyst, using a
microwave irradiation method or a traditional thermal method. This was followed by chlorination
for compounds 13a–e and subsequent nucleophilic substitution of the chlorine group by
ethylenediamine at C2 position of the pyridine ring. The antiproliferative activity of these new
nicotinonitriles was evaluated against human ovarian adenocarcinoma (SK-OV-3), breast
adenocarcinoma (MCF-7), and cervix adenocarcinoma (HeLa) cells. Among all compounds, 2-((2-
aminoethyl)amino)-4-aryl-6-indolylnicotinonitriles series (15a, 15b, 15d, and 15e) exhibited
higher antiproliferative activity cells with IC50 values of 4.1–13.4 μM.
Keywords
Antiproliferative agents; Indole; Indolyl carbonitriles; Microwave-assisted Synthesis;
Multicomponent Reactions
3-Substitued indolyl moiety is a basic constituent in numerous proteins, the neurotransmitter
serotonin, and mammalian hormone melatonin as well as a large number of marketed
available pharmaceutical drugs. For instance, indomethacin (1), naratriptan (2), tegaserod
(3), ondansetron (4), zafirlukast (5), sunitinib (6), sertinole (7), and panobinostat (8) (Figure
1) contain 3-substituted indole scaffold in their chemical structures.1
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Additionally, several marine indole alkaloids have been isolated and evaluated for their
anticancer, antiviral, and antiinflammatory activities. Meridianins A–E (9) were isolated
from tunicate Aplidium Meridianm.2,3 Bisindolyl alkaloids spaced by five or six membered
heterocyclic moieties, such as piperazinone (Hamacanthin B, 10), quinone (Asterriquinone,
11), or imidazole (Nortopsentins A–C, 12) (Figure 1) have exhibited modest to high
anticancer activities against a wide range of human cell lines at micromolar
concentrations.4–6
Furthermore, nicotinonitrile skeletons especially those with amino substituent at C2 and/or
4,6-diaryl-substitutent have demonstrated broad range of biological activities, such as
antibacterial,8, antifungal9, antituberculosis10, antiviral11, antipyretic, analgesic, and
antiinflammatory12–14 effects.
Furthermore, they have been used as inhibitors for protein kinase, topoisomerase15,16,
phosphodiesterase17,18 as well as antiproliferative agents for the treatment of a number of
human cancer cell lines.19–21
The application of one-pot multicomponent reactions (MCRs) and microwave-assisted have
been demonstrated to offer smooth reaction conditions and higher overall yield when
compared to classical synthesis methodologies.22–28 Bis(3′-indolyl)pyridine and
pyrazolopyridine-indolyl derivatives have been previously synthesized through MCR and/or
microwave assisted reactions29a.b according to the previously reported procedure29c.
In continuation of our efforts to synthesize and evaluate new indole derivatives as
antiproliferative agents,30 we designed novel indole-3-cyanopyridine hybrid structures to
determine the substituent effects at C2 and C4 on the cytotoxic potency of this scaffold.
Although other heterocyclic indolyl derivatives have been previously synthesized,29 To the
best of our knowledge this is the first microwave-assisted synthesis of hybrid indole and 3-
cyano-4-arylsubstituted pyridine compounds and evaluation of their antiproliferative
activities.
Considering the advantages of MCRs approach and microwave irradiation, 3-acetyl indole
ketone reacted with ethyl cyanoacetate and a series of aromatic aldehydes with an excess of
ammonium acetate under microwave irradiation for 15–20 min affording novel 4-aryl-6-
indolyl-nicotinonitrile-2-one derivatives (13a–e) (Scheme 1). All compounds were
characterized by mass, and NMR spectroscopy (Supplementary Material).
Ethylene glycol and piperidine were used as a solvent and a catalyst, respectively, during the
microwave reaction at a power of 250 W and 150 °C for a given time. The reactions were
successful in achieving the benefits of both utilizing microwave irradiation and the one-pot
MCRs. Compared to the traditional thermal method, the reaction time was shortened from
hours to minutes with improvement in both the target product purity and overall product
yield (77–87%) in case of microwave method. The results for each entry are summarized in
(Table 1).
The mechanism of one pot syntheses of nicotinonitrile derivatives is known to be through
the formation of α,β-unsaturated ketones intermediate via Claisen-Schimdt reaction between
active methylene containing ketones and aromatic aldehydes using catalytic amount (10%)
of strong bases like sodium hydroxide, triethylamine, or piperidine. This reaction is followed
by condensation with nitrile containing active methylene compounds (e.g. ethyl
cyanoacetate or malononitrile) through Michael addition reaction in the presence of
ammonium acetate, cyclization, and aromatization to afford the corresponding 4-aryl-2-
oxo-1H-pyridine-3-carbonitrile derivatives31 (Scheme 2).
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Results in Table 1 showed that, the electronic effect and the nature of the substituent on the
aromatic aldehyde ring played a critical effect in terms of reaction time and product yield
under smilar reaction conditions. When aromatic aldehydes bearing a strong electron
withdrawing group (e.g. 4-fluorine, 4-chloro, 4-bromo) in para positions was used, the yield
of the products was increased in a shorter reaction time compared to those carrying electron
donating groups (e.g. 4-methoxy group) in para position under a similar reaction condition.
Moreover, the reaction of compounds 13a–e with phosphoryl chloride for 18–24 h afforded
the corresponding 2-chloropyridine derivatives (14a–e) after thermal heating at 80 °C as
shown in Scheme 3. 2-Chloropyridine derivatives (14a–e) were used as precursors for
nucleophilic substitution reaction with ethylenediamine under a reflux condition in ethanol
to afford the corresponding 2-aminoethylenamino 6-indolylnicotinonitrile derivatives (15a–
e), The chemical structures of these novel compounds 14a–e and 15a–e were elucidated by
IR, mass, and NMR spectroscopy (see Supplementary Material).
The antiproliferative activities of all synthesized compounds in a panel of cancer cell lines
including human ovarian adenocarcinoma (SK-OV-3), breast adenocarcinoma (MCF-7), and
cervix adenocarcinoma (HeLa) cells were evaluated. All compounds (50 μM) were tested
for their anticancer potency after 72 h incubation. DMSO (3%) and doxorubicin (Dox 10
μM) were used as negative and positive controls for the assay.
As it is shown in Figure 2, compounds 13a, 13c, 13d, 13e, 14a, 14c, and 14d did not show
any significant antiproliferative activity against HeLa, SK-OV-3, and MCF-7 cells. Among
all derivatives, compounds 13b, 14b, and 15a–e showed modest to high antiproliferative
potency. However, compounds 15b, 15d, and 15e showed comparable potency with that of
Dox in HeLa cells and significantly higher potency in SK-OV-3 and MCF-7 cells versus
Dox. For example, compounds 15b, 15d, and 15e inhibited the proliferation of HeLa, SK-
OV, and MCF-7 cells by 62–67%, 85–88%, and 84–87%. Interestingly, these three
compounds inhibited the cell proliferation of SK-OV-3 and MCF-7 cells with higher
potency compared to that of HeLa cells, indicating that their activity was cell-specific.
All synthesized compounds have a common scaffold of conjugated substituted 6-indolyl
pyridine ring. Compounds 15a–e also have an ethylene-1,2-diamine moiety attached to the
substituted pyridine ring. Changing the substation at C2 from oxo (compounds 13a–e) to
ethylene-1,2-diamine (compounds 15a–e) showed that, an ethylene-1,2-diamine moiety
plays a significant role in elevating the anti-proliferative activity. However, among indolyl
nicotinonitrile (15a–e), compound 15c with p-fluorophenyl substituent at C4 did not show
similar potency when compared with the other compounds in this series, suggesting that the
presence of a strong electron withdrawing fluorine group is not productive. On the other
hand, the presence of a heterocyclic ring as in compound 15a or an electron donating group
like p-methoxy group as in compound 15b resulted in higher antiproliferative activity. Thus,
electronic effect of the substituent of the phenyl group substituent appears to have a direct
effect on antiproliferative activity.
Based on the results from the preliminary screening, compounds 15a, 15b, 15d, and 15e
were selected for further IC50 evaluation. IC50 is the concentration that causes 50%
inhibition of cancer cell growth. The IC50 values of 15a, 15b, 15d, and 15e derivatives were
tested in HeLa, SK-OV-3, and MCF-7 cells (Table 2). As it is shown in the IC50 graphs
(Figure S1, Supplementary Material), all these four derivatives showed high potency in the
inhibition of the proliferation of different cancer cells. The IC50 values of compounds 15a,
15b, 15d, and 15e were in the range of 4.1–13.4 μM, 6.5–8.1 μM, 5.9–7.1 μM, and 5.8–8.8
μM, respectively, in HeLa, SK-OV-3, and MCF-7 cells. Compounds 15a and 15e showed
slightly lower IC50 values in MCF-7 and SK-OV-3 cells compared to the other compounds.
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The partition coefficient (Log P) of all the synthesized compounds were calculated by using
ChemDraw 10.0 (Supplementary information, Table S1). The data revealed that the
compounds 15a–e with moderate Log P values of 3.23–4.19 showed significantly higher
antiproliferative activity compared to other compounds possibly because of higher cellular
uptake of these compounds).32 Compounds 13a–e with low Log P values (2.43–3.28) did
not show high antiproliferative activity, while compounds 14a–e with high lipophilicity
(Log P = 4.82–5.77) showed moderate activity. These data indicate that there is a correlation
between the partition coefficient and antiproliferative activity of these compounds, and an
optimal Log P is required for generating maximum activity.
In conclusion, we have demonstrated a facile and efficient method for the preparation of a
new series of 6-indolypyridine-3-carbonitrile derivatives via the one-pot MCR with the
microwave-assisted irradiation affording high yields, short reaction times, and the easy
workup procedure. Among all compounds, 2-((2-aminoethyl)amino)-4-aryl-6-
indolylnicotinonitrile series (15a, 15b, 15d, and 15e) exhibited higher antiproliferative
activity than Dox against SK-OV-3, MCF-7, and HeLa cells. These data suggest that
indolylnicotinonitriles chemical scaffold can be used as a template for further structure
optimization for generating compounds with higher antiproliferative activity.
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Figure 1.
Common biologically active 3-substituted indolyl derivatives.
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Figure 2.
Antiproliferative activity of 13a–e, 14a–e, and 15a–e.
El-Sayed et al. Page 7
Tetrahedron Lett. Author manuscript; available in PMC 2015 February 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Scheme 1.
Synthesis of indolylnicotinonitriles (13a–e). Reagents and conditions: (a) piperidine (1 mL),
ethylene glycol (1 mL), MW irradiation (W 250 and T 150 °C).
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Scheme 2.
Mechanistic illustration for the formation of 2-oxo-1,2-dihydropyridine-3-carbonitrile
system.
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Scheme 3.
Reagents and conditions: (a) POCl3, reflux, 80 °C for 18–24 h; (b) ethylenediamine, ethanol,
reflux, 36–48 h.
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Table 2
IC50 values of four selected compounds in SK-OV-3, MCF-7, and HeLa cells.
Entry HeLaa SK-OV-3 MCF-7
15a 13.4 4.7 4.1
15b 7.2 6.5 8.1
15d 6.8 5.9 7.1
15e 8.8 5.8 6.8
Dox 0.1533a 3.2 7.5
33 b
a
The IC50 values of compounds were calculated in μM. The data are average of triplicate experiments.
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